Effects of Mycoplasma hyopneumoniae vaccine on pigs naturally infected with M. hyopneumoniae and porcine reproductive and respiratory syndrome virus

Vaccine

Volumn 22, Issue 17-18, 2004, Pages 2328-2333

  Moreau, Isabelle A ^a,c   Miller, Gay Y ^a   Bahnson, Peter B ^b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c Biovet Inc   (Canada)

Author keywords

Mycoplasma hyopneumoniae; Porcine reproductive and respiratory syndrome virus; Vaccine

Indexed keywords

BACTERIAL VACCINE; INGLEVAC; MYCOPLASMA HYOPNEUMONIAE VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIVIRUS; ARTICLE; BACTERIAL INFECTION; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFECT; FEMALE; MALE; MORTALITY; MYCOPLASMA HYOPNEUMONIAE; NONHUMAN; ONSET AGE; PRIORITY JOURNAL; SWINE; VACCINATION; VIRUS INFECTION; WEIGHT GAIN;

ANIMALS; ANTIBODIES, VIRAL; BACTERIAL VACCINES; FEMALE; MALE; MYCOPLASMA HYOPNEUMONIAE; PNEUMONIA OF SWINE, MYCOPLASMAL; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; SURVIVAL ANALYSIS; SWINE; VACCINATION; VACCINES, INACTIVATED; WEIGHT GAIN;

EID: 2442684394     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2003.10.041     Document Type: Article

References (22)

1. Ross RF. Mycoplasmal diseases. In: Straw BE, D'Allaire S, Mengeling WL, Taylor DJ, editors. Diseases of swine. Ames, IO: Iowa State University Press; 1999. p. 495-509.
2. Thacker E.L., Halbur P.G., Ross R.F., Thanawongnuwech R., Thacker B.J. Mycoplasma hyopneumoniae potentiation of porcine reproductive and respiratory syndrome virus-induced pneumonia. J. Clin. Microbiol. 37:1999;620-627
3. Van Alstine W.G., Stevenson G.W., Kanitz C.L. Porcine reproductive and respiratory syndrome virus does not exacerbate Mycoplasma hyopneumoniae infection in young pigs. Vet. Microbiol. 49:1996;297-303
4. Pallares F.J., Gomez S., Ramis G., Seva J., Munoz A. Vaccination against swine enzootic pneumonia in field conditions: effect on clinical, pathological, zootechnical and economic parameters. Vet. Res. 31:2000;573-582
5. Maes D., Deluyker H., Verdonck M., Castryck F., Miry C., Vrijens B., et al. Effect of vaccination against Mycoplasma hyopneumoniae in pig herds with an all-in/all-out production system. Vaccine. 17:1999;1024-1034
6. Maes D., Deluyker H., Verdonck M., Castryck F., Miry C., Lein A., et al. The effect of vaccination against Mycoplasma hyopneumoniae in pig herds with a continuous production system. J. Vet. Med. B. 45:1998;495-505
7. Maes D., Deluyker H., Verdonck M., Castryck F., Miry C., Vrijens B., et al. Herd factors associated with the seroprevalences of four major respiratory pathogens in slaughter pigs from farrow-to-finish pig herds. Vet. Res. 31:2000;313-327
8. Ciprian A., Cruz T.A., de la Garza M. Mycoplasma hyopneumoniae: interaction with other agents in pigs, and evaluation of immunogens. Arch. Med. Res. 25:1994;235-239
9. Amass S.F., Clark L.K., Van Alstine W.G., Bowerstock T.L., Murphy D.A., Knox K.E., et al. Interaction of Mycoplasma hyopneumoniae and Pasteurella multocida infections in swine. J. Am. Vet. Med. Assoc. 204:1994;102-107
10. Jayappa H, Davis R, Rapp-Gabrielson V, Wasmoen T, Thaker E, Thaker B. Evaluation of the efficacy of M hyopneumoniae bacterin following immunization of young with varying passive antibodies. Proc Am Assoc Swine Veterinarians 2001, 24-27 February, Nashville, TN, pp. 237-41.
11. Moore C, Daigneault J. The effect of timing of vaccination with respisure to prevent lung lesions in pigs in presence of a high or a low challenge on Mycoplasma hyopneumoniae. In: Proceedings of the 16th Meeting of the International Pig Veterinary Society, 17-20 September 2000, Melbourne, Australia, p. 495.
12. Harris DL. Multi-site pig production. Ames, IA: Iowa State University Press; 2000.
13. Porstmann B., Evers U., Nugel E., Schmechta H. Tetramethylbenzidin - ein chromogenes Substrat für Peroxidase im Enzymimmunoassay. Zeitschrift für Medizinische Laboratoriumsdiagnostik. 32(1):1991;3-8
14. Anonymous. An annotated dictionary of production and financial terminology. Natl Hog Farmer 1999;44(3):88-98.
15. Miller G.Y., Song Y., Bahnson P.B. An economic model for estimating batch finishing system profitability with an application in estimating the impact of preventive measures for porcine respiratory disease complex. J. Swine Health Prod. 9:2001;169-177
16. Carpenter T.E. Evaluation of effectiveness of a vaccination program against an infectious disease at the population level. Am. J. Vet. Res. 62:2001;202-205
17. Sorensen V., Barfod K., Feld N.C., Vraa-Andersen L. Application of enzyme-linked immunosorbent assay for the surveillance of Mycoplasma hyopneumoniae infection in pigs. Rev. Sci. Technol. 12(2):1993;593-604
18. Polson D, Miller S, Chittick W, Utley P. Measurement of the serum antibody response to a one-dose Mycoplasma hyopneumoniae vaccine and disease challenge in growing pigs using a Tween 20 and competitive ELISA assay. Proceedings of the A.D. leman Swine Conference, 11-15 August 2000, Minneapolis, MN, p-41.
19. K L., Wu C.C., Van Alstine W.G., Knox K.E., Van Alstine G. Evaluation of the effectiveness of a macrolide antibiotic on reduction of respiratory pathogens in 12-day and 21-day weaned pigs. J. Swine Health Prod. 6:1998;257-262
20. Entriken TL, editor. Veterinary pharmaceuticals and biologicals. Lenexa, KS: Veterinary Healthcare Communications; 2001.
21. Wu C.C., Shryock T.R., Lin-Tsang L., Venhuizen M.F. Testing antimicrobial susceptibility against Mycoplasma hyopneumoniae in vitro. J. Swine Health Prod. 5:1997;227-230
22. Boettcher T.B., Thacker B.J., Halbur P.G., Waters W.R., Nutsch R., Thacker E.L. Vaccine efficacy and immune response to Mycoplasma hyopneumoniae challenge in pigs vaccinated against porcine reproductive and respiratory syndrome virus and M. hyopneumoniae. J. Swine Health Prod. 10:2002;259-264